CIRM Funded Clinical Trials
A Phase 2b Study of the Efficacy of a Novel Pro-Neurogenesis/Pro-Plasticity Drug for Bipolar Depression Using a Precision Psychiatry Approach
Disease Area:
Neurological Disorders
Trial Sponsor:
Alto Neuroscience
Trial Stage:
Phase 2
Trial Status:
Launching
Targeted Enrollment:
N/A
